Zacks Investment Research·Jun 30, 2026
Oscar Health, Inc. (OSCR) Stock Dips While Market Gains: Key FactsOscar Health, Inc. (OSCR) closed at $28.52 in the latest trading session, marking a -3.16% move from the prior day.
Oscar Health, Inc.(OSCR)Earnings, Financials & Key Ratios
OSCR•NYSE
$31.12
Price updated Jul 7, 2026
AboutOscar Health, Inc. provides health insurance products and services in the United States. The company offers Individual & Family, Small Group, and Medicare Advantage plans, as well as +Oscar, a technology driven platform designed to help providers and payor clients to engage with members and patients. It also provides reinsurance products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.Show more
- Revenue$11.7B+27.5%
- EBITDA-$367M-511.0%
- Net Income-$443M-1842.5%
- EPS (Diluted)-1.69-1865.9%
- Gross Margin14.38%-28.5%
- EBITDA Margin-3.14%-422.3%
- Operating Margin-3.39%-642.8%
- Net Margin-3.79%-1466.7%
- ROE-44.38%-1690.2%
OSCR Price & Volume
Oscar Health, Inc. (OSCR) stock price & volume — 10-year historical chart
Loading chart...
Rapid Revenue Scaling Drives Recent Profitability Inflection
Investment Thesis • Updated 2026Q1
VerdictNeutral
Growth:Accelerating
Profitability:Moderate
Financial:Healthy
Cash Flow:Improving
Primary Risk:Regulatory ACA Subsidy Exposure
Key Thesis Takeaways
- Oscar Health has demonstrated a significant operational pivot, evidenced by 52.6% year-over-year revenue growth in 2026Q1 and a transition to $679.0 million in net income.
- While the company has successfully decoupled administrative costs from membership expansion, the sustainability of these margins remains uncertain due to historical volatility and reliance on seasonal working capital swings.
- Investors should monitor the company's ability to maintain this profitability trajectory, as the current 28.57 forward P/E ratio reflects high expectations for continued scale without the historical burden of stock-based compensation.
Verdict Logic
while the company achieved a 14.6% net margin in 2026Q1, the extreme quarterly variance in cash flow and historical reliance on ACA subsidy timing warrant a cautious approach until long-term profitability is proven.
OSCR Growth Metrics
Oscar Health, Inc. (OSCR) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years81.77%
3 Years41.55%
TTM31.95%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-131.97%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-307.69%
Return on Capital
10 Years-24.08%
5 Years-24.41%
3 Years-10.85%
Last Year-25.31%
OSCR Recent Earnings
Oscar Health, Inc. (OSCR) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 9/12 qtrs (75%)●Beat Revenue 6/12 qtrs (50%)
Q2 2026Latest
May 6, 2026Metric
Actual
Est
EPS
$2.07+71.1%
$1.21
Rev
$4.6B-6.4%
$4.9B
Q1 2026
Feb 10, 2026Metric
Actual
Est
EPS
$1.24-34.6%
$0.92
Rev
$2.7B-12.1%
$3.1B
Q4 2025
Nov 6, 2025Metric
Actual
Est
EPS
$0.53+3.6%
$0.55
Rev
$3.0B-2.2%
$3.1B
Q3 2025
Aug 6, 2025Metric
Actual
Est
EPS
$0.89+1.1%
$0.90
Rev
$2.9B-6.8%
$3.1B
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 6, 2026 | $2.07vs $1.21+71.1% | $4.6Bvs $4.9B-6.4% |
| Q1 2026 | Feb 10, 2026 | $1.24vs $0.92-34.6% | $2.7Bvs $3.1B-12.1% |
| Q4 2025 | Nov 6, 2025 | $0.53vs $0.55+3.6% | $3.0Bvs $3.1B-2.2% |
| Q3 2025 | Aug 6, 2025 | $0.89vs $0.90+1.1% | $2.9Bvs $3.1B-6.8% |
Based on last 12 quarters of dataView full earnings history →
Latest OSCR News
Recent stock market news and headlines for Oscar Health, Inc. (OSCR)
Zacks Investment Research·Jun 24, 2026
Oscar Health, Inc. (OSCR) Declines More Than Market: Some Information for InvestorsOscar Health, Inc. (OSCR) concluded the recent trading session at $29.16, signifying a -2.57% move from its prior day's close.
GuruFocus·Jun 23, 2026
Oscar Health Inc (OSCR) Stock Up 4.9% but GF Value Says Overvalued -- GF Score: 79/100On June 23, 2026, Oscar Health Inc (OSCR) shares rose 4.9% to a current price of $29.93, reflecting a strong performance in the market. The stock has experience
GuruFocus·Jun 15, 2026
A Look at Oscar Health Inc (OSCR) After 3.1% Gain -- GF Value $20.91 vs Price $29.14On June 15, 2026, Oscar Health Inc (OSCR) shares rose 3.1% to $29.14, continuing a strong upward trend with a remarkable year-to-date increase of 102.8%. The st
Peers Comparison
Key metrics vs top competitors for Oscar Health, Inc. (OSCR)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $31.12 | $8.07B | -18.41 | 27.5% | -3.79% | -44.38% | — | |
| $5.00 | $2.59B | -29.41 | 40.34% | -2.58% | -17.08% | — | |
| $24.05 | $4.91B | -6500.00 | 46.06% | 0.47% | 11.5% | — | |
| $102.85 | $35.93B | 8.85 | 14.27% | 24.73% | 20.48% | — | |
| $15.55 | $1.65B | -2.27 | — | — | -866.46% | — | |
| $0.95 | $39.83M | -0.70 | — | — | -140.83% | — |
Compare OSCR vs Peers
Oscar Health, Inc. (OSCR) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
OSCR SEC Filings & Documents
Oscar Health, Inc. (OSCR) SEC filings — annual & quarterly reports (10-K, 10-Q)
8-K Announcements
6Material company update
May 6, 2026·SEC
Material company update
Apr 21, 2026·SEC
Material company update
Mar 2, 2026·SEC
10-K Annual Reports
310-Q Quarterly Reports
6Get notified when OSCR posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
OSCR Frequently Asked Questions
Oscar Health, Inc. (OSCR) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
What is Oscar Health, Inc.'s revenue?
Oscar Health, Inc. (OSCR) reported $13.30B in revenue for fiscal year 2025. This represents a 2302% increase from $553.8M in 2019.
How fast is Oscar Health, Inc. growing?
Oscar Health, Inc. (OSCR) grew revenue by 27.5% over the past year. This is strong growth.
Is OSCR profitable?
Oscar Health, Inc. (OSCR) reported a net loss of $39.4M for fiscal year 2025.
Dividend & Returns
What is OSCR's return on equity?
Oscar Health, Inc. (OSCR) has a return on equity (ROE) of -44.4%. Negative ROE indicates the company is unprofitable.
What is Oscar Health, Inc.'s free cash flow?
Oscar Health, Inc. (OSCR) generated $2.80B in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.